AMRX - CAH BLUE among premarket gainers May, 11 2020 09:26 AM Amneal Pharmaceuticals Inc. Class A Cellect Biotechnology (NASDAQ:APOP) +126% on publication of ApoGraft data ahead of clinical trial.More news on: Cellect Biotechnology Ltd., MyoKardia, Inc., AMC Entertainment Holdings, Inc., Stocks on the move, , Read more ...